An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Sakimoto, Susumu ^a,b   Kidoya, Hiroyasu ^a   Kamei, Motohiro ^b   Naito, Hisamichi ^a   Yamakawa, Daishi ^a   Sakaguchi, Hirokazu ^b   Wakabayashi, Taku ^a,b   Nishida, Kohji ^b   Takakura, Nobuyuki ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN (22-52); ADRENOMEDULLIN ANTIBODY; ADRENOMEDULLIN RECEPTOR; CD31 ANTIGEN; CD45 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN INHIBITOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE;

ADRENOMEDULLIN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD31; ANTIGENS, CD45; CELL LINE; CELL PROLIFERATION; CHOROIDAL NEOVASCULARIZATION; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; LASERS; MACROPHAGES; MACULAR DEGENERATION; MICE; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874784614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058096     Document Type: Article

References (39)

1. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314: 989-992.
2. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J, (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 3578-3585.
3. Tsutsumi-Miyahara C, Sonoda KH, Egashira K, Ishibashi M, Qiao H, et al. (2004) The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br J Ophthalmol 88: 1217-1222.
4. Xie P, Kamei M, Suzuki M, Matsumura N, Nishida K, et al. (2011) Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344. PLoS One 6: e28933.
5. Xiong M, Elson G, Legarda D, Leibovich SJ, (1998) Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153: 587-598.
6. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, et al. (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246.
7. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, et al. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339.
8. Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R, (2006) Adrenomedullin and tumour angiogenesis. Br J Cancer 94: 1-7.
9. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, et al. (2004) Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res 95: 415-423.
10. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, et al. (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104: 1964-1971.
11. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, et al. (2003) Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 22: 1238-1242.
12. Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, et al. (2009) Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice. FASEB J 23: 3424-3435.
13. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, et al. (2002) Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 160: 1279-1292.
14. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, et al. (2003) Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 17: 1937-1939.
15. Ribatti D, Nico B, Spinazzi R, Vacca A, Nussdorfer GG, (2005) The role of adrenomedullin in angiogenesis. Peptides 26: 1670-1675.
16. Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, et al. (2000) Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 6: 2808-2814.
17. Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, et al. (2009) A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 29: 2469-2480.
18. Campa C, Kasman I, Ye W, Lee WP, Fuh G, et al. (2008) Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci 49: 1178-1183.
19. Naito H, Kidoya H, Sakimoto S, Wakabayashi T, Takakura N, (2011) Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels. EMBO J 31: 842-855.
20. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, et al. (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell 102: 199-209.
21. Sakimoto S, Kidoya H, Naito H, Kamei M, Sakaguchi H, et al. (2012) A role for endothelial cells in promoting the maturation of astrocytes through the apelin/APJ system in mice. Development 139: 1327-1335.
22. Grossniklaus HE, Kang SJ, Berglin L, (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29: 500-519.
23. Chen P, Huang Y, Bong R, Ding Y, Song N, et al. (2011) Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner. Clin Cancer Res 17: 7230-7239.
24. Kubo A, Minamino N, Isumi Y, Katafuchi T, Kangawa K, et al. (1998) Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 273: 16730-16738.
25. Ogita T, Hashimoto E, Yamasaki M, Nakaoka T, Matsuoka R, et al. (2001) Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells. J Hypertens 19: 603-608.
26. Udono T, Takahashi K, Nakayama M, Murakami O, Durlu YK, et al. (2000) Adrenomedullin in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 41: 1962-1970.
27. Saita M, Shimokawa A, Kunitake T, Kato K, Hanamori T, et al. (1998) Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am J Physiol 274: R979-984.
28. Boguslawski G, McGlynn PW, Harvey KA, Kovala AT, (2004) SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro. J Biol Chem 279: 5716-5724.
29. Eto T, (2001) A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22: 1693-1711.
30. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, et al. (1993) Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241: 271-273.
31. Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, et al. (1997) Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96: 1983-1990.
32. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, et al. (2002) Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91: 618-625.
33. Abe M, Sata M, Suzuki E, Takeda R, Takahashi M, et al. (2006) Effects of adrenomedullin on acute ischaemia-induced collateral development and mobilization of bone-marrow-derived cells. Clin Sci (Lond) 111: 381-387.
34. Iwase T, Nagaya N, Fujii T, Itoh T, Ishibashi-Ueda H, et al. (2005) Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation 111: 356-362.
35. Kong XQ, Wang LX, Yang CS, Chen SF, Xue YZ, et al. (2008) Effects of adrenomedullin on the cell numbers and apoptosis of endothelial progenitor cells. Clin Invest Med 31: E117-122.
36. Chen L, Qiu JH, Zhang LL, Luo XD, (2012) Adrenomedullin promotes human endothelial cell proliferation via HIF-1alpha. Mol Cell Biochem 365: 263-273.
37. Pugh CW, Ratcliffe PJ, (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
38. Udono T, Takahashi K, Nakayama M, Yoshinoya A, Totsune K, et al. (2001) Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42: 1080-1086.
39. Huang W, Wang L, Yuan M, Ma J, Hui Y, (2004) Adrenomedullin affects two signal transduction pathways and the migration in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 1507-1513.